Skip to content

LITHI - PHARMA

Active
Public limited companyfounded 199333 yrs activeZomerloosstraat 33, 8470 Gistel, BelgiumKBO/BCE: BE 0449.135.041

LITHI - PHARMA has been active since 1993 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €553k and a net result of €-224k. Equity is growing by ~11.4% per year across the filed fiscal years. Its solvency ranks better than 51% of 875 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).

Checked score

Score 2025
15 / 100
Critical▼ -38 vs 2024
The score combines four axes. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability0=
Solvency45▼-24
Growth52▼-26
Stability100
Bankruptcy probability, 12 months
0.2% Very low
0%0.5%1.5%4%10%≥ 25%
No credit on open account
Liquidity short (current ratio 0.34 against 1.29 in 2024), and 65.6% of the assets are financed with debt.
Credit advice for your own amount and term

Signals

Eight signals. The signal on the left, the evidence on the right.
lowers risk+raises riskneutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 93
Relative position
BE, all sectors
reference
Sector 93
lower
← fewer bankruptcies more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation date
Age against the risk zone
elevated failure risk from 2 to 8 years 33 years 0 40 y
raises risk · Multiple establishment units
Several establishment units mean more fixed costs, and such companies fail more often than a company with one establishment.
KBO · establishment units
lowers risk · Lower-risk legal form
Companies with this legal form statistically fail less often than a BV.
KBO · legal form
raises risk · Persistent losses
Two consecutive loss-making years (2024 and 2025); equity fell accordingly. May indicate structural pressure on profitability.
NBB · annual accounts 2025
Net result per financial year
19202122232425
2019 to 2025 · latest year -€224k
neutral · Latest accounts filed on time
The financial year that closed on 30-06-2025 was due by 31-01-2026 and was filed on 29-12-2025, 33 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
33 d early
2024
33 d early
2023
23 d early
2022
31 d early
2021
62 d early
2020
53 d early
2019
28 d early
← before the deadline after the deadline →
neutral · The next deadline is still running
The next financial year closes on 30-06-2026 and is due by 31-01-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
30-06-2026 close12-09-2026 today31-01-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2025, abbreviated schema

Equity
€553k▼ 28.8%
2024 · €777k
2019: €118k 2020: €163k 2021: €647k 2022: €675k 2023: €795k 2024: €777k
2019 → 2025
Total assets
€1.61M▼ 18.4%
2024 · €1.97M
2019: €1.14M 2020: €1.07M 2021: €1.71M 2022: €2.32M 2023: €2.26M 2024: €1.97M
2019 → 2025
Net result
€-224k▼ 1,118%
2024 · €-18k
2019: €-29k 2020: €45k 2021: €484k 2022: €28k 2023: €120k 2024: €-18k
2019 → 2025
Working capital
€-229k
2024 · €116k
2019: €-779k 2020: €-614k 2021: €10k 2022: €37k 2023: €311k 2024: €116k
2019 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise ▼ fall
Line20212022202320242025Trend
Equity€647k-€675k▲ 4.4%€795k▲ 17.7%€777k▼ 2.3%€553k▼ 28.8%
Operating result€658k-€-19k€150k€-13k€-252k▼ 1,830%
Net result€484k-€28k▼ 94.2%€120k▲ 324%€-18k€-224k▼ 1,118%
Turnover and EBIT margin not published: the abbreviated or micro schema does not require them.
Result per fiscal year
Operating resultNet result
€-500k€-250k€0€250k€500k€750kOperating result 2021: €658k€658kNet result 2021: €484k€484kOperating result 2022: €-19k€-19kNet result 2022: €28k€28kOperating result 2023: €150k€150kNet result 2023: €120k€120kOperating result 2024: €-13k€-13kNet result 2024: €-18k€-18kOperating result 2025: €-252k€-252kNet result 2025: €-224k€-224k20212022202320242025
The operating result stays negative: a loss of €252k in 2025 against €13k in 2024; the loss grows and 2025 is the lowest year so far.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €1.61M
Fixed assets €1.49M▲ 2.4%
Current assets €116k▼ 77.5%
Equity and liabilities €1.61M
Equity €553k▼ 28.8%
Provisions €134k▼ 20.0%
Debt €923k▼ 10.4%
The debt ratio rises from 52.2% to 57.3%: equity shrinks faster than debt is paid down.
Key figures and ratios
2025 value · change against 2024
EBITDA
€-215k
2024 · €32k
Cash flow
€-187k
2024 · €27k
Solvency
34.4%
2024 · 39.3%
Current ratio
0.34
2024 · 1.29
Quick ratio
0.34
2024 · 1.29
Debt / equity
1.67
2024 · 1.33
ROE
-40.4%
2024 · -2.4%
ROA
-13.9%
2024 · -0.9%
Interest coverage
-21.70
2024 · 2.41
Debt
€923k
2024 · €1.03M
Debt ≤ 1 year
€345k
2024 · €400k
Debt > 1 year
€578k
2024 · €630k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet Code20242025
Assets
Total assets20/58€1.97M€1.61M
Fixed assets21/28€1.46M€1.49M
Tangible fixed assets22/27€1.13M€1.17M
Land and buildings22€1.12M€1.17M
Plant, machinery and equipment23€2k€542
Furniture and vehicles24€9k€3k
Financial fixed assets28€325k€325k=
Current assets29/58€515k€116k
Amounts receivable within one year40/41€513k€86k
Trade receivables40€4€34k
Other amounts receivable41€513k€52k
Cash at bank and in hand54/58€2k€25k
Deferred charges and accrued income490/1€347€5k
Equity and liabilities
Total equity and liabilities10/49€1.97M€1.61M
Equity10/15€777k€553k
Contributions10/11€200k€200k=
Capital10€200k€200k=
Issued capital100€200k€200k=
Reserves13€508k€401k
Non-distributable reserves130/1€6k€6k=
Legal reserve130€6k€6k=
Tax-exempt reserves132€503k€396k
Profit (loss) carried forward14€69k€-48k
Provisions and deferred taxes16€168k€134k
Deferred taxes168€168k€134k
Amounts payable17/49€1.03M€923k
Amounts payable after more than one year17€630k€578k
Financial debts170/4€630k€578k
Amounts payable within one year42/48€400k€345k
Current portion of amounts payable after more than one year42€55k€56k
Financial debts43€405-
Credit institutions430/8€405-
Trade debts44€2k€70k
Suppliers440/4€2k€70k
Taxes, remuneration and social security45€5k€10k
Taxes450/3€3k€9k
Remuneration and social security454/9€1k€1k=
Other amounts payable47/48€338k€208k
Accrued charges and deferred income492/3€899€817
Income statement Code20242025
Non-recurring operating income76A-€53k
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€45k€37k
Other operating charges640/8€9k€365k
Gross operating margin9900€41k€150k
Operating profit (loss)9901€-13k€-252k
Financial income75/76B-€5k
Recurring financial income75-€5k
Financial charges65/66B€13k€10k
Recurring financial charges65€13k€10k
Profit (loss) for the period before taxes9903€-26k€-257k
Transfer from deferred taxes780€8k€34k
Profit (loss) for the period9904€-18k€-224k
Transfer from tax-exempt reserves789€24k€107k
Profit (loss) for the period to be appropriated9905€6k€-117k
Appropriation of the result
Profit (loss) to be appropriated9906€69k€-48k
Profit (loss) brought forward from the previous period14P€63k€69k
Transfer to equity691/2€282-
To the legal reserve6920€282-

The notes to these accounts (15 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-01-2027
2026
10-08
State Gazette act General meeting · Director reappointment
Permanent representative
2025
29-12
NBB filing Annual accounts filed
fiscal year 2025 · abbreviated schema
30-06
Financial Weakest financial yearnet €-224k
Net result drops to €-224k, the lowest in the series.
2024
29-12
NBB filing Annual accounts filed
fiscal year 2024 · abbreviated schema
08-01
NBB filing Annual accounts filed
fiscal year 2023 · micro schema
2022
31-12
NBB filing Annual accounts filed
fiscal year 2022 · micro schema
2021
30-11
NBB filing Annual accounts filed
fiscal year 2021 · abbreviated schema
30-06
Financial Highest result since 2019net €484k ▲964%
Operating result €658k, net result €484k, both a record.
30-06
Financial Liquidity times 9current ratio 1.01
Current ratio from 0.12 to 1.01.
30-06
Financial Equity above €500kEq €647k ▲296%
2 profitable years in a row build equity to €647k.
2020
09-12
NBB filing Annual accounts filed
fiscal year 2020 · abbreviated schema
30-06
Financial Back to profitnet €45k
Net result €45k after one loss-making year.
30-06
Financial Equity above €150kEq €163k ▲38.6%
Equity rises from €118k to €163k.
03-01
NBB filing Annual accounts filed
fiscal year 2019 · abbreviated schema
2019
07-01
NBB filing Annual accounts filed
fiscal year 2018 · abbreviated schema
2018
08-01
NBB filing Annual accounts filed
fiscal year 2017 · micro schema
2017
03-01
NBB filing Annual accounts filed
fiscal year 2016 · abbreviated schema
Financial milestoneState Gazette actNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

Directors · office · real estate

Directors
no sitting director, no change since 2020
We have established no sitting directors for this company. We derive directors from published Gazette acts; while there are none, or none read, nothing appears here. That does not mean the company has none: the CBE keeps its own list of function holders, which we do not read.
01-01-2020 Resigned as Managing director
Location & real-estate footprint
Registered office, Gistel · 2 establishment units since 1993
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Zomerloosstraat 338470 Gistel
Ground area
1,653 m²
Building footprint
520 m²
Volume, LiDAR
3,383 m³
2 parcels, Flanders · tallest building 11.0 m, ±3 floors. Linked by address, not a title deed.
2 establishment units
LITHI-PHARMA
Zomerloosstraat 33/A, 8470 GistelNACE 74151
since 19932.060.503.692
El Solito
Stationsstraat 79, 8470 GistelPersonal service activities
since 20142.229.208.369
2 parcels
Flanders 2 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
35005A1053/00N000 Flanders 910 m² 1 · 140 m² 6.5 m · 1 fl.
35005B0271/00R000 Flanders 742 m² 1 · 379 m² 11.0 m · 3 fl.
Linked by address, not proof of ownership
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Structure & network

Ownership & control

1 party
LITHI - PHARMABE 0449.135.041
controls
Where this company holds controlthis company sits on their board1
1 location

Similar companies · same sector, comparable size

Of 1,512 companies in sector 93130 we hold annual accounts for 684. 351 are within a factor 10 of this equity.See the whole sector

Company data · Crossroads Bank

Identification
Legal formPublic limited company
Founded06-01-1993
Fiscal year end30-06
Activities, NACEBEL
93130Fitness centres
Sources
Crossroads Bank for EnterprisesNational Bank · 32 filingsAddress and cadastre registers

Data from official sources, last processed on 12-09-2026. Scores and ratios are computed by Checked and are not a credit decision.